Latest News

  • CARAT Fellowship Programme 2019: Seven exceptional scientists benefit from unique know-how

    To enable more and more experts to use innovative cell manufacturing technology: this is the goal of the CARAT Training Fellowship Programme. In December 2019, seven talented scientists participated in the TCT training course at the MACS Academy in Bergisch Gladbach.
  • ATMP-Workshop: CAR T cell therapies in Europe

    Despite the potential of CAR T cell therapies, there are still significant hurdles in Europe to be overcome during their development, approval process, and reimbursement. On December 3 over hundred experts met at the invitation of BIO.NRW and Miltenyi Biotec at ATMP Workshop in Brussels to come up with solutions and make these novel therapies...
  • Joint CARAT/RESTORE survey to identify obstacles in translation of CAR T and ATMP into clinical application

    CARAT together with the EU initiative RESTORE are conducting a joint survey within our research networks to identify the most important technological, regulatory, clinical and ethical hurdles for translation of CAR T and ATMP into clinical application. The short anonymous survey includes just 12 questions and will take roughly 7 minutes to...
  • Taking the Final Leap: CARAT Meeting in Bergisch Gladbach

    It seems like yesterday that the CARAT partners met for the first time at their kick-off meeting in Bergisch Gladbach, Germany, in 2016. Now, almost four years later on 4-5 November 2019, the consortium returned to the same place to conclude the project. The meeting was hosted by the coordinator Miltenyi in the impressive Kardinal Schulte Haus...
  • CAR T cell therapy in solid tumours

    While CAR T cell therapy has been very successful in the past years with regard to hematologic malignancies, the translation to solid tumours remains a challenge. Now, the results of two trials in the US with mesothelin and claudin 18.2 targeted CAR T cells are very promising and indicate that the therapy can be successfully applied also to...
  • CARAT Continues Its Journey in the Field of CAR T Cell Therapy

    Having entered the final project year, the CARAT consortium gathered on 7-8 March, 2019 in Langen, Germany, for their 4th Progress Meeting. The meeting was hosted by Paul-Ehrlich-Institut, a German federal authority in the field of medicinal products and partner in CARAT. While the project progress was assessed extensively by the partners during...
  • CARAT Training Fellowship

    GMP-compliant CAR T Cell Manufacturing Training Course December 9-13, 2019
  • Out now: The CARAT animated clip is online

    Entering the final project year, the CARAT consortium is happy to announce the release of an animated clip illustrating the project work and its possible impact on cellular cancer treatments of the future. The short animation aims to showcase the project approach and goals in an easy-to-understand and entertaining format in order to inform...

Upcoming Events